Mead Johnson Nutrition Company

MEAD JOHNSON NUTRITION COMPANY SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Investigates Sale to Reckitt Benckiser Group plc

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Mead Johnson Nutrition Company (“Mead Johnson”) (NYSE: MJN) concerning the sale to Reckitt Benckiser Group plc. Under the terms of the agreement, Mead Johnson shareholders will only receive $90.00 for each share owned, which is lower than the 52-week high and at least one analyst’s estimated value of $95.00 per share.

If you are an affected investor, and you want to learn more about the investigation or if you have information that you believe would be helpful to our investigation of the fairness of the proposed transaction, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at [email protected] or by calling (888) 809-2750. There is no cost or fee to you.

The investigation centers on whether Mead Johnson’s Board of Directors is acting in the shareholders’ best interests, whether the board considered alternatives to the acquisition, and whether the board has employed an adequate process to review and act on the proposed transaction. Notably, at least one analyst with Yahoo! Finance believes the true inherent value of the stock could be as high as $95.00.

The Briscoe Law Firm, PLLC is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

EN
13/02/2017

Reports on Mead Johnson Nutrition Company

Please Change Name Brian Weddington ... (+2)
  • Please Change Name Brian Weddington
  • CFA

Mead Johnson Nutrition Co.: Update to Discussion of Key Credit Factors...

CORPORATES CREDIT OPINION 16 June 2017 Update RATINGS Mead Johnson Nutrition Co. Domicile Glenview, ILLINOIS, United States Long Term Rating A3 Type Senior Unsecured - Dom Curr Outlook No Outlook Please see the ratings section at the end of this report for more information. The ratings and outlook shown reflect information as of the publication date. Contacts Brian Weddington, CFA 212-553-1678 VP-

Please Change Name Brian Weddington ... (+2)
  • Please Change Name Brian Weddington
  • CFA

Moody's upgrades Mead Johnson notes to A3 on Reckitt Benckiser guarant...

Rating Action: Moody's upgrades Mead Johnson notes to A3 on Reckitt Benckiser guarantee. Global Credit Research- 15 Jun 2017. Approximately $3 billion of debt instruments affected.

 PRESS RELEASE

Mead Johnson Nutrition Merger with Reckitt Benckiser Completed

CHICAGO--(BUSINESS WIRE)-- Mead Johnson Nutrition Company (MJN) announced today that its merger with Reckitt Benckiser Group plc (RB) has been completed. As a result of the transaction, Mead Johnson’s common stock is no longer traded on the New York Stock Exchange, effective today. Mead Johnson is now a division of RB, adding its globally-recognized brands, including Enfa™ and Nutramigen©, to RB’s powerful consumer health portfolio. "We are pleased that the completion of this transaction returns significant and immediate valu...

 PRESS RELEASE

Final Approval Received for Acquisition of Mead Johnson by Reckitt Ben...

CHICAGO--(BUSINESS WIRE)-- Mead Johnson Nutrition Company (NYSE: MJN) announced that the final regulatory approval has been received in order to complete its acquisition by Reckitt Benckiser Group plc. The transaction is expected to close on Thursday, June 15, 2017, subject to the satisfaction of customary closing conditions at such time. About Mead Johnson Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. T...

 PRESS RELEASE

Mead Johnson Stockholders Approve Acquisition by RB; Mead Johnson Nutr...

CHICAGO--(BUSINESS WIRE)-- Mead Johnson Nutrition Company (NYSE: MJN) (“Mead Johnson” or the “Company”) announced that its stockholders approved the acquisition of Mead Johnson by Reckitt Benckiser Group plc (“RB”) at a Special Meeting of Stockholders held today in Chicago, Illinois. Shareholders of RB also approved the transaction at a General Meeting held earlier today in London. At Mead Johnson’s Special Meeting, approximately 70.30% of shares outstanding as of the record date were voted in favor of the transaction,...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch